Featured Search - Analysis Shows USPSTF Evidence Backs Mammography at 40
Radiologists from the University of Colorado and the University of Michigan contend that evidence actually shows the benefits of mammography screening women aged 40 to 49 greatly outweigh the possible risks.
Top news from a Feb. 1 featured radiology search on SearchMedica: preventive imaging
United States Preventive Services Task Force Screening Mammography Recommendations: Science IgnoredAmerican Journal of Roentgenology | Feb 1, 2011 (Free abstract. Full text: $10)
Taking a close look at the evidence on which the USPSTF recommended against mammography screening for women aged 40 to 49, radiologists from the University of Colorado and the University of Michigan contend that it actually shows the benefits greatly outweigh the possible risks.
Related Content from Diagnostic Imaging:
The USPSTF Breast Cancer Screening Guidelines: Current and Future Implications
Several months have passed since the publication of the latest US Preventive Services Task Force (USPSTF) breast cancer screening guidelines. The initial, sharp outcry, mainly over the task force’s recommendation against routine screening mammography for women aged 40 to 49 years, has somewhat subsided, but the overall significance of the group’s decision remains undetermined.
Experts Outraged as FDA Panel Says Screening Mammography Should Begin at 50
The U.S. Preventive Services Task Force has issued a recommendation against routine breast cancer screening for women ages 40 to 49 and suggests the screening interval should be changed from every year to every two years beginning at age 50. The new recommendations will result in "many needless deaths," said a joint statement from the American College of Radiology and the Society of Breast Imaging.
Preview: Mammography Rallies on Political Leap Forward
The technological and political evolution of digital mammography will be in evidence on the RSNA exhibit floor.
Mammography Study Compares False Positives Between AI and Radiologists in DBT Screening
May 8th 2025For DBT breast cancer screening, 47 percent of radiologist-only flagged false positives involved mass presentations whereas 40 percent of AI-only flagged false positive cases involved benign calcifications, according to research presented at the recent American Roentgen Ray Society (ARRS) conference.
